4//SEC Filing
KHOSLA CHAITAN PHD 4
Accession 0001104659-24-070939
CIK 0001604191other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 6:23 PM ET
Size
6.6 KB
Accession
0001104659-24-070939
Insider Transaction Report
Form 4
KHOSLA CHAITAN PHD
Director
Transactions
- Award
Common Stock
2024-06-11+24,889→ 24,889 total
Holdings
- 440(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]On June 11, 2024, the Reporting Person was granted 24,889 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest in three equal increments on July 1, 2024, September 30, 2024, and December 31, 2024.
- [F2]Includes unvested RSUs.
- [F3]Held directly by the Chaitan Khosla Living Trust, in which the Reporting Person serves as the sole Trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Entero Therapeutics, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001135139
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 6:23 PM ET
- Size
- 6.6 KB